Personalization of Cover Letter and Response Rate

March 23, 2020 updated by: Anne Illemann Christensen, University of Southern Denmark

Personalization of Cover Letter and Response Rate - a Randomized Controlled Trial in the Danish Health and Morbidity Survey

Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. In the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background and aim: In the Danish Health and Morbidity Surveys the participation rate has declined from 61% in 2010 to 57% in 2013. A declining participation rate may affect the representativeness and the results of the survey. Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. The research question, then, is whether cover letters with targeted content can perform better than a standard letter. The proposition is that such letters should increase the willingness of some sample members to participate, and that this will be reflected in higher response rates. However, little is known about which targeted content is the most effective.

Thus, in the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys. Further, given that the majority of sample members participate, these sample members who are swayed by the targeted letter must have relatively low response propensities (with the standard letter). Thus, we hypothesize that targeted letters should particularly improve response rates in low response propensity subgroups (i.e. young men, unmarried, and elderly women). A secondary research question is, therefore, whether any effect of targeted letters on response rate is greater among sample subgroups with low response propensities.

Design: A randomized trial will be incorporated the Danish Health and Morbidity Survey 2017 where a paragraph in the cover letter intended to heighten perceptions of relevance of the survey is varied among sample members. The Danish Health and Morbidity Survey 2017 will be based on a nationally representative random sample of 25,000 individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017. The sample will be drawn from the adult population in Denmark using the Danish Civil Registration System and the survey will be conducted between February 3 and Maj 5, 2017. All sample members will be randomly allocated, with equal probabilities, to one of 11 treatment groups. One group will receive a standard letter that is designed to have general appeal and the other 10 groups will receive one of 10 versions of the targeted cover letter. In the previous Health and Morbidity Surveys, all sample members received the same standard letter. Much of the content of the standard letter and the targeted letter will be the same. The intention is to hold constant features designed to demonstrate the credibility of the survey, to allay fears about confidentiality, to appeal to self-interest, and to provide basic information about the task of participation. All sample members will be invited either to complete a web questionnaire or to fill out a paper questionnaire concerning health and morbidity.

Statistics: The analysis will be based on logistic regression modelling of the 25,000 persons invited to the Health and Morbidity Survey 2017. The independent variable is a dichotomous indicator of treatment group: targeted or standard letter. The dependent variable indicates whether the sample member has fully or partially completed the questionnaire. The mediator variable indicates membership of each of three operationally important low response propensity groups (i.e. young men, unmarried, and elderly women). The approach is to first test for a main effect of the independent variable in each of the treatment groups. A second step is to conduct the same analysis stratified by treatment group. A third step will then seek to identify whether any significant effects occurs between the mediator variable and dependent variable.

Study Type

Interventional

Enrollment (Actual)

25000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 1353
        • National Institute of Public Health, University of Southern Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Standard cover letter

The group will receive a standard cover letter to the survey that is designed to have broad appeal:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark.

EXPERIMENTAL: Targeted cover letter 1

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sleep problems.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 2

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and contact to family and friends.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 3

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sex

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 4

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and contact to family and friends.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 5

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and sex.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 6

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sex and contact to family and friends.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 7

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and contact to family and friends.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 8

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and alcohol.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 9

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, alcohol and contact to family and friends.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
EXPERIMENTAL: Targeted cover letter 10

This group will receive a cover letter to the survey including the paragraph:

You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as alcohol, sleep problem and contact to family and friends.

The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall response rate
Time Frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)
Response rate overall and in the different intervention arms
Up to 3 months (from February 3 2017 to maxium Maj 5 2017)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Response rate in different subgroups
Time Frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)
Response rate in different subgroups with low response propensity
Up to 3 months (from February 3 2017 to maxium Maj 5 2017)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Janne S Tolstrup, MD PhD, National Institute of Public Health - University of Southern Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 3, 2017

Primary Completion (ACTUAL)

May 19, 2017

Study Completion (ACTUAL)

June 1, 2018

Study Registration Dates

First Submitted

February 2, 2017

First Submitted That Met QC Criteria

February 4, 2017

First Posted (ESTIMATE)

February 8, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 24, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 60110-5060-FL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Response Rate

Clinical Trials on Targeted cover letter

Subscribe